Skip to main
GTHX
GTHX logo

G1 Therapeutics (GTHX)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy G1 Therapeutics (GTHX) Stock

About G1 Therapeutics (GTHX)

G1 Therapeutics, Inc. engages in the development of small molecule therapeutics for the treatment of patients with cancer. Its products pipeline includes trilaciclib, rintodestrant, and lerociclib. The company was founded by Kwok-Kin Wong and Norman E. Sharpless on May 19, 2008 and is headquartered in Research Triangle Park, NC.
Market cap$377.22M
Today's volume
Revenue (TTM)$58.2M
Avg. daily volume1.97M
EBITDA (TTM)-$37.39M
Open
Price / earnings ratio-8.30x
Today's range
Debt / equity195.04x
52 week range$1.08 - $7.19
5 year debt / equity70.93x
Beta (LTM)1.57x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio2.48x
Ex-dividend date
Next earningsAug 26, 2025
Dividend payable date

G1 Therapeutics Stock Rating

What analysts recommend for GTHX stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 60%
Buy 30%
Hold 10%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Aug 11, 2025, the market cap for GTHX stock is $377.23M

The current P/E ratio for GTHX stock is -8.3

The 52-week high for GTHX stock is $7.19. The current GTHX stock price $undefined is 100.00% below its 52-week high

The 52-week low for GTHX stock is $1.08. The current GTHX stock price $undefined has increased 100.00% from its 52-week low

No, the GTHX stock does not pay dividends to its shareholders

The target price for GTHX stock is $27.20 based on the average of what a group of analyst think GTHX stock could be worth at a future date. This is not a prediction by Public.com

How to buy GTHX stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in GTHX stock

    Navigate to the Explore page. Then, type GTHX into the search bar. When you see GTHX stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased GTHX stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

G1 Therapeutics Stock Earnings

The value each GTHX share was expected to gain vs. the value that each GTHX share actually gained.

G1 Therapeutics (GTHX) reported Q2 2024 earnings per share (EPS) of -$0.10, beating estimates of -$0.17 by 41.18%. In the same quarter last year, G1 Therapeutics's earnings per share (EPS) was $0.14. G1 Therapeutics is expected to release next earnings on 08/26/2025, with an earnings per share (EPS) estimate of $0.

Buy G1 Therapeutics (GTHX) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.